Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Validation of Timed 25-Foot Walk Benchmarks in People with Multiple Sclerosis
Multiple Sclerosis
P15 - Poster Session 15 (12:00 PM-1:00 PM)
9-017

This study further evaluated the convergent and divergent validity of T25FW performance benchmarks based on differences in the physical functioning and emotional well-being scales of the 36-Item Short-Form Health Survey (SF-36) in a large sample of people with MS.

 

The Timed 25-foot Walk (T25FW) is the most widely applied performance measure for quantifying walking dysfunction in people with multiple sclerosis (MS). This wide-spread application is based on its psychometric properties for capturing changes in walking over time and with intervention. Such application has further resulted in the initial development of benchmarks for interpreting the meaning of T25FW performance standards in MS.

Cross-sectional data on T25FW, SF-36 physical functioning, and SF-36 emotional well-being were collected during baseline testing from 491 participants with MS enrolled in a large-pragmatic trial. Convergent validity and divergent validity were evaluated by comparing adjusted means of the SF-36 physical functioning and emotional well-being scores across four T25FW performance benchmarks: < 6 seconds, 6-7.99 seconds, ≥8 seconds, and unable to complete.

The SF-36 physical functioning adjusted mean scores were significantly different across the four T25FW performance benchmarks (< 6 seconds: 69.5 [95% CI 65.4 to 73.6]; 6-7.99 seconds: 46.3 [95% CI 41.5 to 51.1]; ≥8 seconds: 22.5 [95% CI 18.2 to 26.9]; Unable to complete: 10.3 [95% CI 1.0 to 19.5]).  The SF-36 emotional well-being adjusted mean scores were similar across the four T25FW performance benchmarks (< 6 seconds: 74.3 [95% CI 70.3 to 78.2]; 6-7.99 seconds: 69.4 [95% CI 64.7 to 74.0];  ≥8 seconds: 68.6 [95% CI 64.5 to 72.8]; Unable to complete: 81.0 [95% CI 72.2 to 89.9]).

T25FW performance benchmarks were associated with different degrees of physical functioning while no association with emotional well-being was observed in participants with MS. Further validation analysis needs to be conducted with other objective measures of walking performance.

Authors/Disclosures
Emily S. Riser, MD (Alabama Neurology Associates)
PRESENTER
Dr. Riser has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
Tapan Mehta, MD (University of Connecticut, Hartford Hospital) Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt, Medtronic, J&J, Terumo.
No disclosure on file